Roche launches Foundation Medicine-partnered genomic profiling kit
Product designed to allow laboratories to expand in-house oncology research
Read More
Tag: Foundation Medicine
AZ signs up Foundation Medicine for Lynparza diagnostic
AstraZeneca has signed up Foundation Medicine to develop a novel companion diagnostic assay for its cancer drug Lynparza that will enable doctors to identify patients most likely to benefit from it.
Read More
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
